Ratings CompuGroup Medical SE & Co. KGaA

Equities

COP

DE000A288904

Market Closed - Xetra 11:35:08 2024-04-26 EDT 5-day change 1st Jan Change
28.5 EUR +2.30% Intraday chart for CompuGroup Medical SE & Co. KGaA -2.46% -24.80%

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Analyst opinion has improved significantly over the past four months.

Weaknesses

  • The group shows a rather high level of debt in proportion to its EBITDA.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Software

1st Jan change Capi. Investor Rating ESG Refinitiv
-24.80% 1.59B
C+
+11.17% 322B
B-
+24.75% 216B
B+
+2.41% 149B
B
+10.65% 56.27B
D+
+8.71% 32.13B
B+
-4.57% 27.45B
C+
+103.03% 22.62B
D+
+20.22% 19.55B
B-
+13.06% 14.69B
B
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. COP Stock
  4. Ratings CompuGroup Medical SE & Co. KGaA